Protalix BioTherapeutics
PLX
PLX
36 hedge funds and large institutions have $3.4M invested in Protalix BioTherapeutics in 2018 Q2 according to their latest regulatory filings, with 4 funds opening new positions, 7 increasing their positions, 8 reducing their positions, and 3 closing their positions.
Holders
36
Holders Change
+1
Holders Change %
+2.86%
% of All Funds
0.83%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
4
Increased
7
Reduced
8
Closed
3
Calls
$17K
Puts
$34K
Net Calls
-$17K
Net Calls Change
+$1K
Top Buyers
| Name | Holding | Trade Value |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
FDCDDQ
26
Federation des caisses Desjardins du Quebec
Levis,
Quebec, Canada
| $4.73K | – | – | – |
|
27
UBS Group
Zurich,
Switzerland
| $4K | -$38.1K | -10,098 | -91% |
|
|
CB
28
Commerce Bank
Kansas City,
Missouri
| $4K | – | – | – |
|
29
Bank of America
Charlotte,
North Carolina
| $3K | – | – | – |
|
30
Royal Bank of Canada
Toronto,
Ontario, Canada
| $2K | – | – | – |
|
|
SPIA
31
Steward Partners Investment Advisory
New York
| $1K | – | – | – |
|
32
SEI Investments
Oaks,
Pennsylvania
| $1K | – | – | – |
|
33
DZ Bank
Frankfurt Am Main,
Germany
| – | -$187K | -34,650 | Closed |
|
|
ZF
34
Zhang Financial
Portage,
Michigan
| – | -$23K | -4,500 | Closed |
|
|
GC
35
Guggenheim Capital
Chicago,
Illinois
| – | -$22K | -4,038 | Closed |
|